Afimetoran not checked

Bristol Myers Squibb · BMS-986256 · BLN-256

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
2 active
9 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus, Systemic Lupus Erythematosus
Main trialPhase 2/3
“This study is evaluating whether afimetoran, an investigational oral medicine that blocks toll-like receptors 7 and 8 (TLR7/TLR8), can improve skin disease in adults with active cutaneous lupus erythematosus (CLE), with or without systemic lupus, whose disease has not responded to or who cannot tolerate antimalarial therapy. Participants are assigned by chance to receive afimetoran or a matching placebo capsule once daily for 24 weeks, in addition to their existing standard lupus care. Neither participants nor study staff know which treatment is given. The study is run in two stages under a…”In the company’s words, NCT07881120 on ClinicalTrials.gov
Other names
BMS-986256 · BLN-256

Other drugs for Cutaneous Lupus Erythematosus (CLE)

All 15 drugs for Cutaneous Lupus Erythematosus (CLE)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials9

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting Apr 2030 Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus
Phase 2Active, not recruiting 12 Jun 2026 A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Phase 1Completed 21 Feb 2020 A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participants
Phase 1Completed 21 Mar 2021 Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
Phase 1Completed 30 Mar 2021 Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants
Phase 1Completed 24 Sep 2021 A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
Phase 1Completed 21 Apr 2023 A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus
Phase 1Completed 29 Sep 2023 A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
Phase 1Completed 11 Apr 2024 A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Afimetoran

Following is part of Solo: you see every change to Afimetoran the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in